Nepafenac PCD Pharma Franchise Company
Cafoli Lifecare offers 3 Nepafenac formulations in eye drop and eye/ear drop presentations for its ophthalmic franchise partners. All products are manufactured at WHO-GMP certified facilities and offered on a monopoly basis.
What is Nepafenac?
Nepafenac is a topical non-steroidal anti-inflammatory prodrug for ophthalmic use. After penetrating the cornea it is converted to amfenac, which inhibits cyclo-oxygenase and reduces intraocular prostaglandin synthesis, controlling post-operative inflammation and pain. Further detail is available on MedlinePlus.
Therapeutic Applications
Nepafenac is used for the treatment of pain and inflammation associated with cataract surgery and to reduce the risk of post-operative macular oedema, particularly in diabetic patients. It is prescribed by ophthalmologists and cataract surgeons.
Why Nepafenac is a High-Potential Molecule for Distributors
Cataract surgery is performed in enormous numbers across India, in both private and charitable hospitals, and every procedure generates a defined post-operative drop regimen. That makes Nepafenac's demand surgical-volume-driven and highly predictable, and it pairs naturally with an antibiotic eye drop such as Moxifloxacin in the same institutional call.
Why Choose Cafoli Lifecare
Cafoli offers district-wise monopoly rights, WHO-GMP certified manufacturing, DCGI-approved formulations, competitive net rates and complete promotional inputs, with 1000+ franchise partners across India.
References
- MedlinePlus: Nepafenac (ophthalmic)
- PubChem: Nepafenac
Our formulations of Nepafenac find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: